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Mechanisms of Neointima Formation and Remodeling in the
Porcine Coronary Artery
Thomas Christen, MD, PhD; Vitali Verin, MD; Marie-Luce Bochaton-Piallat, PhD;
Youri Popowski, MD; Frans Ramaekers, PhD; Philippe Debruyne, MD; Edoardo Camenzind, MD;
Guillaume van Eys, PhD; Giulio Gabbiani, MD, PhD
Background—To characterize the cells responsible for neointima formation after porcine coronary artery wall injury, we
studied the expression of smooth muscle cell (SMC) differentiation markers in 2 models: (1) self-expanding stent
implantation resulting in no or little interruption of internal elastic lamina and (2) percutaneous transluminal coronary
angioplasty (PTCA) resulting in complete medial rupture and exposure of adventitia to blood components.
Methods and Results—The expression of a-smooth muscle (SM) actin, SM myosin heavy chain isoforms 1 and 2, desmin,
and smoothelin was investigated by means of immunohistochemistry and Western blots in tissues of the arterial wall
collected at different time points and in cell populations cultured from these tissues. The expression of smoothelin, a
marker of late SMC differentiation, was used to discriminate between SMCs and myofibroblasts. Both stent- and
PTCA-induced neointimal tissues and their cultured cell populations expressed all 4 markers. The adventitial tissue
underlying PTCA-induced lesions temporarily expressed a-SM actin, desmin, and SM myosin heavy chain isoforms, but
not smoothelin. When placed in culture, adventitial cells expressed only a-SM actin.
Conclusions—Our results suggest that SMCs are the main components of coronary artery neointima after both
self-expanding stent implantation and PTCA. The adventitial reaction observed after PTCA evolves with a chronology
independent of that of neointima formation and probably corresponds to a myofibroblastic reaction. (Circulation. 2001;
103:882-888.)
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Percutaneous transluminal coronary angioplasty (PTCA) isessential in the treatment of coronary disease.1 Resteno-
sis, occurring in 30% to 40% of patients, represents a major
limitation of this procedure. The advent of coronary stenting
has resulted in a significant (30% to 50%) decrease of
restenosis rate.2 However, the new entity of “in-stent reste-
nosis” resistant to any available therapy has emerged.3
According to a contemporary paradigm, several phenom-
ena are involved in restenosis development after PTCA.4 One
is proliferation and migration of medial smooth muscle cells
(SMCs) into the intima.5 It was recently suggested that
adventitial myofibroblasts are capable of traversing the rup-
tured media and thus participate in the formation of neointi-
mal thickening.6,7 Another is unfavorable constrictive remod-
eling of the artery, possibly related to activation and
proliferation of adventitial fibroblasts.4,6,7 It is noteworthy
that stent implantation eliminates the constrictive remodeling
of the artery but does not interfere with neointima formation.4
It is conceivable that implantation of a self-expanding stent
(Wallstent) into a porcine coronary artery leads to a chronic
injury of the wall, resulting in the migration of medial SMCs
into the intima.8 Conversely, a balloon overstretch injury,
resulting in complete rupture of the media and exposure of
the adventitia to blood components, could lead (in addition to
SMC stimulation) to activation and proliferation of adventi-
tial fibroblasts, followed by their inward migration and
participation in neointima formation.6,7 To acquire more
knowledge on the origin of cells responsible for neointima
formation in both models, we studied chronologically the
expression of well-established SMC differentiation markers,
ie, a-smooth muscle (SM) actin,9 SM myosin heavy chain
(MHC) isoforms 1 and 2,9 desmin,9 and smoothelin,10 in the
arterial wall layers after stent implantation or PTCA. We also
studied the same differentiation markers in cell populations
cultured from these tissues under normal conditions and after
both injuries. The expression of smoothelin, a marker of late
SMC differentiation, was used to discriminate between SMCs
and myofibroblasts.11
We demonstrate that (1) a self-expanding stent induces a
neointima composed of cells expressing all SMC markers
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tested, without producing a myofibroblastic reaction in the
adventitia; (2) PTCA-induced neointima essentially contains
cells with SMC features; and (3) the myofibroblastic reaction
taking place in the adventitia after PTCA evolves indepen-
dently of neointima formation.
Methods
Animals and Standard Procedure Protocol
Domestic crossbred pigs (Sus scrofa) weighing ’40 kg were
premedicated with azaperone (60 mg/10 kg; Janssen Pharmaceuti-
cal), midazolam (10 mg; Roche Pharma), and 0.25 mg atropine IM.
The pigs were sedated by continuous injection of fentanyl (0.2 mg/h
IV). After endotracheal intubation, the animals were ventilated with
halothane (1.5 vol%; Zeneca), nitrous oxide, and oxygen to maintain
anesthesia throughout the experiment. The left common carotid
artery was surgically exposed, and after insertion of the introducer
(8F, Input.PS; Bard), acetylsalicylic acid (1 g; Synthelabo) and
heparin (Liquemine 100 IU/kg; Roche Pharma) were administered
intra-arterially. The coronary ostia were cannulated, and arteries
were then injured either by direct self-expanding stent implantation
(Wallstent, Schneider) without subsequent balloon inflation or by an
oversized PTCA balloon inflation (Bonnie, Schneider) with a
balloon-to-artery diameter ratio of 1.2 to 1.3. The balloon was
inflated 3 times for 30 seconds. Noninstrumented coronary arteries
and coronary arteries of pigs from a nearby slaughterhouse served as
controls. After closure of cervicotomy and local antibiotic treatment,
the animals received 106 IU of penicillin G (Hoechst-Pharma) IM.
The pigs were euthanized under general anesthesia by whole-heart
explantation, and coronary arteries were dissected from the sur-
rounding myocardium. Histology and immunohistochemistry were
performed on specimens collected at 4 (stent and PTCA, n51), 7
(stent, n53; PTCA, n54), 15 (stent and PTCA, n53), and 30 (stent,
n53; PTCA, n54) days. Tissues for digestion and protein extract
preparation were harvested from normal media (n55), 30-day-old
stent- and PTCA-induced neointimas (stent, n53; PTCA, n51 for
protein extraction and n53 for digestion), and adventitial tissue
either normal (n53) or underlying 7-day-old PTCA-induced injury
(n53). As controls for adventitial fibroblasts, we placed in culture
subcutaneous fibroblasts from the skin of the neck. All animal
procedures were performed according to federal veterinary guide-
lines and approved by the Ethical Committee of the Geneva Medical
Faculty.
Histology and Immunohistochemistry
Normal coronary arteries and segments containing a stent- or a
PTCA-induced lesion were fixed with 4% neutral buffered formalin
and embedded in paraffin or snap-frozen in precooled liquid isopen-
tane and embedded in OCT resin (Miles Scientific). Paraffin-
embedded sections were stained with hematoxylin and eosin and
Miller, Landrum, or Alcian blue stains. For indirect immunofluores-
cence, cryostat sections were stained with mouse monoclonal IgG2a
specific for a-SM actin,9 mouse monoclonal IgG1 specific for
desmin (Clone D33; Dako), rabbit polyclonal IgG specific for SM
MHC (Biomedical Technologies Inc; this antibody does not recog-
nize nonmuscle isoform B12), or mouse monoclonal IgG1 specific
for smoothelin10 as previously described.9 Appropriate second anti-
bodies coupled to fluorescein and rhodamine were applied as
previously described.9 Slides were observed with a Zeiss Axiophot
photomicroscope (Carl Zeiss) equipped with a Plan-Neofluar 310/
0.50 objective. Pictures were acquired with a high-sensitivity Cool-
view color camera (Photonic Science). For quantification of differ-
entiation marker expression, neointimal cells were counted either
with a Zeiss Axiophot photomicroscope with an oil immersion
Plan-Apochromat 340/1.3 or 363/1.25 objectives or by overlaying
pictures of double-stained tissues with the help of KS 400 software
(Zeiss Vision).
To confirm coexpression of a-SM actin and smoothelin in vivo,
slides were further examined with a confocal laser scan fluorescence
inverted microscope (CLSM 410; Carl Zeiss) through an oil immer-
sion Plan-Neofluar 363/1.4 objective as previously described.9 A
3D image corresponding to the projection of all optical sections in 1
plane was reconstructed with the Imaris program (Bitplane) running
on an Octane Silicon Graphics Workstation. Images were processed
with Adobe Photoshop 5.0 (Adobe System).
Cell Culture
The intimal thickening present between the struts and the lumen was
separated from the stent and the underlying media with 2 ophthal-
mologic tweezers. Lesion sites induced by PTCA were localized
with the help of binoculars once the vessel was opened longitudi-
nally, and the intimal thickening was collected with a sharp ophthal-
mologic curette. Normal adventitia was stripped free of medial
tissue. All dissected tissues were validated by histology. Normal
media, intimal thickenings, and adventitia were digested, and iso-
lated cells were cultured in DMEM (Gibco BRL, Life Technologies)
containing 10% FCS (HyClone) as previously described.9
Protein Extraction, Electrophoresis, and
Western Blotting
Dissected tissues were immediately frozen in liquid nitrogen and
crushed. Tissues and cell cultures were processed for SDS-PAGE,
with protein load adjusted according to the method of Bradford, and
immunoblotted as previously described.9 In separate experiments,
filters were incubated with either anti–a-SM actin, anti–SM MHC,
anti-desmin, or anti-smoothelin antibodies.9,10,12 Signals were digi-
tized by means of an Arcus II scanner (Agfa) and analyzed with
Image Quant software (Image Quant Analysis; Molecular Dynam-
ics). Values were normalized to the pixel values measured in normal
media.
Results
Histology of Neointima Formation After Stenting
or PTCA
Representative pictures of coronary artery segments with
stent- or PTCA-induced lesions, stained for elastin and
collagen at 7, 15, and 30 days, are shown in Figure 1. The
Figure 1. Histological appearance of stent- vs PTCA-induced
lesions. Miller staining of porcine coronary artery after 7 (a, b),
15 (c, d), and 30 (e, f) days of stent implantation (a, c, e) and
PTCA (b, d, f). Intimal thickening is important in both conditions
but is more exuberant after PTCA where it extends below the
external elastic lamina (d, arrow). Bar5200 mm.
Christen et al Mechanisms of Neointima Formation 883
internal elastic lamina was only slightly compressed in
stented arteries (Figure 1, a, c, and e), whereas both internal
elastic lamina and media were interrupted in all arteries after
balloon angioplasty (Figure 1, b, d, and f). In both models,
deposition of fibrin and accumulation of inflammatory cells
were seen at 4 days (data not shown); from 7 days on,
spindle-shaped cells started to accumulate within the neoin-
tima (Figure 1, a and b) and gradually increased in quantity
up to 30 days. Stent implantation induced an inflammatory
reaction characterized by the presence of macrophages
around the metallic struts. Fifteen days after PTCA, spindle-
shaped cells infiltrated the space left by media interruption
and extended below the external elastic lamina (Figure 1d,
arrow). Thirty days after stent implantation or PTCA, the
neointima was always thicker than the adjacent media (Figure
1, e and f).
Remarkably, no significant changes were observed in the
adventitia of stented arteries (Figure 2a). In contrast, the
adventitia underlying PTCA-induced lesions showed clear
inflammatory and fibrotic changes with a progressive accu-
mulation of collagen, whereas the neointima was strongly
positive for Alcian blue staining, as previously described.13
At 30 days, the adventitia of PTCA-treated arteries was
always thicker than that of noninjured or stented arteries
(Figure 2b).
Expression of SMC Differentiation Markers After
Stenting or PTCA
Stented coronary arteries were double-stained for either
a-SM actin and smoothelin or SM MHC and desmin at 7, 15,
and 30 days (Figure 3; Table). At 7 days, 16% of the cells of
the thin neointima expressed a-SM actin and SM MHC
(Figure 3, a and g, respectively; Table). The same pattern of
staining was observed for smoothelin and desmin; however,
only 44% and 58% of SMCs positive for a-SM actin and SM
MHC were also positive for smoothelin and desmin, respec-
tively (Figure 3, d and j; Table). At 15 days, 93% of the
neointimal cells were positive for a-SM actin and SM MHC
(Figure 3, b and h; Table), of which 99% and 76% were
positive for smoothelin and desmin, respectively (Figure 3, e
and k; Table). At 30 days, 95% of neointimal cells were
positive for a-SM actin, SM MHC, and smoothelin (Figure 3,
c, i, and f, respectively; Table), but only 49% were positive
for desmin (Figure 3l; Table); areas negative for SMC
markers were limited around the struts of the stent. Practically
all SMCs in the underlying media expressed all 4 differenti-
ation markers regardless of the time of study; only areas
around the stent struts, containing inflammatory cells, re-
Figure 2. Comparison of stent- vs PTCA-induced adventitial
reaction. Miller staining after 30 days of stent implantation (a)
and PTCA (b) shows that no significant changes are present
after stent implantation, whereas an important fibrotic reaction is
present in adventitia (A) and extends into surrounding connec-
tive tissue after PTCA. Bar5200 mm.
Figure 3. Expression of differentiation markers in stented coro-
nary arteries. Immunofluorescence staining showing expression
of a-SM actin (a through c) and smoothelin (d through f) or SM
MHC (g through i) and desmin (j through l) at 7 (a, d, g, j), 15 (b,
e, h, k), and 30 (c, f, i, l) days. Cells of neointima express all dif-
ferentiation markers, whereas cells of underlying adventitia do
not. L indicates lumen. Bar5200 mm. Inset magnification is 3
times that of figure.
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mained negative. The adventitial fibroblasts in stented arter-
ies remained negative for all differentiation markers at 4 (data
not shown), 7, 15, and 30 days. Taken together, these data
suggest that a self-expanding stent induces a neointima
composed of SMCs derived from the underlying media.
In 7-day-old PTCA-induced lesions, 26% of the cells
filling in the gap induced by media interruption expressed
a-SM actin and SM MHC (Figure 4, a and g; Table); of these,
44% were positive for smoothelin and 94% positive for
desmin (Figure 4, d and j, Table). Smoothelin was more
frequently observed in neointimal cells adjacent to the inter-
rupted media (Figure 4d). After 15 days, 94% of the cells
filling the gap were expressing a-SM actin and SM MHC
(Figure 4, b and h; Table), of which 95% and 70% were
positive for smoothelin and desmin, respectively (Figure 4, e
and k; Table). After 30 days, the pattern of staining was
similar to that of 15 days (Figure 4, c, f, i, and l). a-SM actin
and SM MHC were present in 98% of neointimal cells
(Figure 4, c and i; Table); of these, 96% and 55% coexpressed
smoothelin and desmin, respectively (Figure 4, f and l;
Table). The intensity of smoothelin staining was variable; in
’23% of intimal cells, smoothelin staining, although appre-
ciable, was weaker than that of the remaining intimal cells.
This could be related to a variable degree of differentiation of
intimal SMCs.
Seven days after PTCA, the adventitia contained cells
positive for a-SM actin (Figure 4a) and desmin (Figure 4j),
and to a lesser extent SM MHC (Figure 4g). At 15 days, the
adventitial cells expressing a-SM actin (Figure 4b) were still
numerous, whereas only a few expressed SM MHC and
desmin (Figure 4, h and k, respectively). At 30 days, only a
few adventitial fibroblasts expressed a-SM actin, and all were
negative for SM MHC and desmin (Figure 4, c, i, and l,
respectively). No smoothelin-positive cells were detected in
the adventitia at any time point (Figure 4, d, e, and f). These
data are compatible with a myofibroblastic reaction of the
adventitia after PTCA.
For a more detailed analysis of a-SM actin and smoothelin
expression in PTCA-induced neointima, CLSM was used. In
7-day-old PTCA-induced neointima, all spindle-shaped cells
expressed a-SM actin. Among them, some coexpressed
smoothelin importantly (Figure 5, double arrow, yellow
color), and others showed either weak (single arrow, yellow
and green) or no (arrowhead, only green) smoothelin
expression.
Immunoblots of total protein extracts obtained from the
normal media, intimal thickening 30 days after stent implan-
tation or PTCA, normal adventitia, and adventitia underlying
7-day-old PTCA confirmed the results obtained by immuno-
fluorescence staining (Figure 6). a-SM actin, SM MHC
isoforms 1 and 2, desmin, and smoothelin were clearly
expressed in both stent-induced (Figure 6, lane g) and
Percentages of Neointimal SMCs Expressing Differentiation
Markers at Different Times After Injury
Days After Injury
Stent PTCA
7 15 30 7 15 30
a-SM actin 16 93 95 26 94 98
Smoothelin 7 92 94 11 89 94
SM MHC 16 93 95 26 94 98
Desmin 9 71 47 24 66 54
Figure 4. Expression of differentiation
markers in coronary arteries after PTCA.
Immunofluorescence staining showing
expression of a-SM actin (a through c)
and smoothelin (d through f) or SM MHC
(g through i) and desmin (j through l) at 7
(a, d, g, j), 15 (b, e, h, k) and 30 (c, f, i, l)
days. Cells in neointima express all differ-
entiation markers, including smoothelin,
whereas adventitial fibroblasts express
differentiation markers to some extent,
with exception of smoothelin. Note that at
30 days, adventitial staining has practi-
cally disappeared. This evolution is similar
to that of a reactive granulation tissue.
Dotted lines highlight limit of media/neo-
intima. L indicates lumen. Bar5200 mm.
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PTCA-induced (Figure 6, lane h) neointima. In stent-induced
neointima, the content of a-SM actin was decreased to 70%,
that of SM MHC 1 to 60% and of SM MHC 2 to 30%, that
of desmin to 8%, and that of smoothelin to 25% compared
with normal media (Figure 6, lanes g and f).9 In PTCA-
induced neointima, the content of a-SM actin was decreased
to 40%, that of SM MHC 1 to 40% and of SM MHC 2 to
35%, that of desmin to 6%, and that of smoothelin to 20%
compared with normal media (Figure 6, lanes h and f).9 The
normal adventitia was negative for all 4 differentiation
markers (Figure 6, lane i), whereas in adventitia underlying
7-day-old PTCA-induced lesions, the content of a-SM actin
was 3% and that of desmin 8% compared with normal media
(Figure 6, lanes j and f), and no SM MHC (despite some cells
positive by means of immunofluorescence, see Figure 4g) or
smoothelin was observed (Figure 6, lane j).
Cells were isolated by enzymatic digestion from media and
adventitia of normal coronary arteries and from stent- or
PTCA-induced neointima at 30 days. At passage 5, immuno-
blots showed that cells from the stent-induced neointima
expressed all 4 markers, including smoothelin (Figure 7, lane
f). The content of a-SM actin was decreased to 40%, that of
SM MHC 1 to 70% and SM MHC 2 to 75%, that of desmin
to 15%, and that of smoothelin to 40% compared with normal
media (Figure 7, lanes f and e).9 Cells derived from PTCA-
induced neointima also expressed all 4 markers (Figure 7,
lane g). The content of a-SM actin was decreased to 50%,
that of SM MHC 1 to 30% and SM MHC 2 to 2%, that of
desmin to 15%, and that of smoothelin to 35% compared with
normal media (Figure 7, lanes g and e).9 At passage 5,
adventitial fibroblasts cultured from the normal coronary
artery showed an a-SM actin content of 7% compared with
normal media, but SM MHC, desmin, and smoothelin were
not detectable (Figure 7, lanes h and e). Subcutaneous
fibroblasts at passage 5 showed the same expression profile
with regard to the 4 markers as that of adventitial fibroblasts
(data not shown).
Discussion
To efficiently prevent and/or cure restenosis, it is of para-
mount importance to identify cells responsible for both
Figure 5. CLSM micrograph showing a-SM actin and smooth-
elin expression in 7-day-old PTCA-induced neointima. Cells
were double-stained for a-SM actin (green) and smoothelin
(red). 3D reconstruction shows SMCs coexpressing a-SM actin
and smoothelin (yellow) to variable degrees. Some cells are
negative for smoothelin (arrowhead), some have a low degree of
coexpression (single arrow), and some show almost complete
coexpression (double arrow). Note that there is no expression of
smoothelin alone. Bar515 mm.
Figure 6. Expression of differentiation markers in total protein
extracts of coronary arteries. SDS-PAGE of total protein
extracts (a through e) and immunoblots (f through j) showing
a-SM actin, SM MHC, desmin, and smoothelin expression in
normal media (a and f), stent-induced (b and g) and PTCA-
induced (c and h) neointima at 30 days, and normal adventitia (d
and i) and adventitia underlying a lesion resulting from PTCA (e
and j) at 7 days. Like normal media, stent-induced and PTCA-
induced neointimas show expression of 4 markers. Adventitia
underlying PTCA-induced lesion expresses a-SM actin and
desmin but not smoothelin and SM MHC.
Figure 7. Expression of differentiation markers in total protein
extracts of cultured coronary artery SMCs. SDS-PAGE of total
protein extracts (a through d) and immunoblots (e through h)
showing a-SM actin, SM MHC, desmin, and smoothelin expres-
sion in SMCs cultured from normal media (a and e), stent-
induced neointima at 30 days (b and f), PTCA-induced neoin-
tima at 30 days (c and g), and fibroblasts cultured from normal
coronary adventitia (d and h). Cultured medial (e) and neointimal
(f, g) cells of 2 injury models express 4 markers. Cultured
adventitial fibroblasts (h) express only a-SM actin.
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neointima formation and constrictive remodeling. For this
purpose, we studied 2 distinct types of injury chronologically
in the pig (currently a well-accepted animal model in this
respect14): (1) self-expanding stent implantation, inducing a
chronic injury without rupture of the internal elastic lamina
and of the media and (2) PTCA-induced lesions, which result
in complete medial interruption and expose the adventitia to
the circulating blood, thus facilitating fibroblast activation in
the adventitia.6,7 Our results suggest that SMCs are the main
component of the neointima after both self-expanding stent
and balloon overstretch injuries. They are in agreement with
current views concerning the pathogenesis of stent-induced
lesions,8 whereas the pathogenesis of PTCA-induced lesions
has up to now remained controversial.6,7,15–17
SMC Marker Expression in Tissues of Porcine
Coronary Arterial Wall
We have used well-established markers of SMC differentia-
tion in general and of vascular SMC differentiation in
particular, such as a-SM actin, SM MHC, desmin, and
smoothelin. These markers have been extensively character-
ized during the embryonic and fetal development of smooth
muscle.18 The notions that a-SM actin is the earliest marker
to appear during SMC development18 and that smoothelin is
a late differentiation marker of SMC are currently well
accepted.10,11 These markers, with few exceptions for a-SM
actin,19 are not expressed in fibroblasts of normal tissues but
can be expressed in myofibroblasts present in granulation
tissue or fibrocontractive diseases,19 with the exception of
smoothelin, which represents a selective SMC marker.11
As previously described in other models,20 cells accumu-
lating in the neointima after PTCA first dedifferentiated, then
gradually acquired a positive staining for SMC differentiation
markers, including smoothelin, with practically the same time
course as neointimal cells after stent implantation. At no time
after stent implantation did adventitial fibroblasts express 1 of
the 4 markers. In contrast, after PTCA, adventitial fibroblasts
modulated into myofibroblasts, as indicated by the positive
staining for a-SM actin, SM MHC, and desmin and the
negative staining for smoothelin. It is noteworthy that the
chronology of adventitial myofibroblastic modulation was
clearly different from that of SMC differentiation within the
neointima; moreover, this adventitial reaction was reversible,
as seen during granulation tissue formation or many fibrotic
reactions.21
In an elegant study in which adventitial fibroblasts were
labeled with bromodeoxyuridine, Shi et al15 showed that
during the remodeling of an autologous vein graft, a propor-
tion of neointimal cells was derived from perivascular fibro-
blasts. It has been shown that an important degree of
apoptosis takes place in vein graft SMCs22; thus, the recruit-
ment of perivascular fibroblasts could be specific for this
procedure. Further studies using smoothelin antibodies may
be useful to clarify this point.
When proliferation and SMC marker expression were
investigated in the rabbit carotid artery injury model, a
myofibroblastic reaction appeared to take place in the adven-
titia, and neointima formation consisted of medial SMCs with
only a modest adventitia-to-media cell migration.16 When
fibroblasts transduced with retroviral particles encoding
b-galactosidase were implanted in the adventitia of the rat
carotid artery, some of these cells could be found in neoin-
tima formation after balloon injury.17 The relative proportions
of SMCs and fibroblasts participating in neointima formation
in that model remain to be established.
SMC Marker Expression in Cultured Cells
We and others recently reported that cultured porcine coro-
nary artery SMCs maintain a high degree of differentiation in
vitro,9,23 contrary to what has been reported for rodent arterial
SMCs.18,24 In the present study, SMC marker expression was
very similar in the populations of neointimal SMCs cultured
after either stent or PTCA. Both populations maintained the
expression of all markers, including smoothelin, at passage 5,
indicating a SMC rather than a fibroblastic origin. In contrast,
cultured adventitial fibroblasts showed a SMC marker ex-
pression profile clearly different from that of neointimal cells
and similar to that of subcutaneous fibroblasts; in particular,
they did not show smoothelin expression. Moreover, it has
been reported that porcine coronary SMCs behave differently
in vitro from adventitial fibroblasts and from SMCs of elastic
arteries.23 All these data support, albeit indirectly, the SMC
origin of intimal lesions.
Study Limitations
We cannot exclude the possibility that in our model, a small
proportion of fibroblasts participate actively in neointima
formation. It is conceivable, although far from proven, that
once myofibroblasts have migrated within the media, they are
submitted to the influence of local microenvironmental fac-
tors facilitating full SMC differentiation, including smooth-
elin expression. As discussed above, this possibility is not
reflected by the results of experiments in culture, where
adventitial fibroblasts never expressed smoothelin, whereas
neointimal cells derived from both stent lesions and balloon
overstretch lesions expressed all SMC markers, including
smoothelin. Coculture experiments of SMCs and adventitial
fibroblasts may provide interesting information on the possi-
bility that SMCs modulate the phenotypic profile of fibro-
blasts and vice versa. Another limitation of our study is that
injuries were performed on nonatherosclerotic arteries.
Conclusions
Our results support the view that SMCs are the main
contributor to neointima formation after stent implantation
and balloon overstretch injury and thus appear to represent an
appropriate target for preventive and therapeutic interven-
tions based on the modulation of their mitotic, apoptotic, and
motile activities. In contrast, adventitial fibroblast activation,
and in particular the fibrotic and retractile activities of these
cells,19 may be involved in negative remodeling after PTCA
and hence should be considered in preventive and therapeutic
strategies of restenosis after this intervention.
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